1. Karateev, A.E. and Lila, A.M., Osteoarthritis: Сurrent clinical concept and some promising therapeutic approaches, Nauchno-Prakt.
Revmatol., 2018, vol. 56, no. 1, pp. 70–81.
2. Chichasova, N.V., Imametdinova, G.R., and Lila, A.M., Safe therapy of osteoarthritis: place of topical nonsteroidal anti-inflammatory drugs, Med. Sov., 2020, vol. 8, pp. 128–134.
3. Shirinsky, V.S., Kazygasheva, E.V., and Shirinsky, I.V., Inflammation and immunity: A role of pathogenesis of osteoarthritis, Med. Immunol., 2019, vol. 21, no. 1, pp. 39–48.
4. Raimuev, K.V., Ishchenko, A.M., and Malyshev, M.E., Pro-inflammatory and anti-inflammatory cytokines in the pathogenesis of osteoarthritis, Vestn. Sev.-Zapadn. Gos. Med. Univ.
im.
I.I. Mechnikova, 2018, vol. 10, no. 3, pp. 19–27.
5. Chichasova, N.V., Updated 2016 international guidelines for the management of patients with osteoarthritis: focus on chondroitin sulfate, glucosamine and their combination (Teraflex®), Consilium Medicum, 2017, vol. 19, no. 9, pp. 69–76.